NUWELLIS, INC. (NUWE) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
32/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseNUWE / S&P -91.70% / 15.20% |
LoseNUWE / S&P 8.36% / 15.00% |
LoseNUWE / S&P -99.39% / 50.40% |
| 2026-Q11/3 |
LoseNUWE / S&P -39.66% / -4.33% |
LoseNUWE / S&P -0.20% / 11.30% |
WinNUWE / S&P 121.31% / 27.70% |
| 2025-Q41/3 |
LoseNUWE / S&P -48.06% / 2.65% |
LoseNUWE / S&P -5.38% / 9.00% |
WinNUWE / S&P 125.23% / 13.40% |
| 2025-Q31/3 |
LoseNUWE / S&P -63.74% / 8.12% |
LoseNUWE / S&P -8.93% / 4.61% |
WinNUWE / S&P 218.48% / 13.45% |
| 2025-Q21/3 |
LoseNUWE / S&P -76.60% / 10.94% |
LoseNUWE / S&P -7.72% / 4.83% |
WinNUWE / S&P 160.94% / 10.63% |
| 2025-Q11/3 |
LoseNUWE / S&P -15.32% / -4.27% |
LoseNUWE / S&P -1.21% / 4.98% |
WinNUWE / S&P 340.44% / 10.57% |
| 2024-Q41/3 |
LoseNUWE / S&P -6.72% / 2.41% |
LoseNUWE / S&P -1.40% / 5.25% |
WinNUWE / S&P 378.57% / 6.15% |
| 2024-Q31/3 |
LoseNUWE / S&P -76.34% / 5.89% |
LoseNUWE / S&P 3.66% / 5.89% |
WinNUWE / S&P 364.73% / 6.11% |
| 2024-Q22/3 |
LoseNUWE / S&P -60.08% / 4.28% |
WinNUWE / S&P 8.54% / 5.38% |
WinNUWE / S&P 558.93% / 5.12% |
| 2024-Q11/3 |
LoseNUWE / S&P -37.93% / 10.56% |
LoseNUWE / S&P 5.35% / 5.71% |
WinNUWE / S&P 364.61% / 5.59% |
| 2023-Q41/3 |
LoseNUWE / S&P -59.44% / 11.69% |
LoseNUWE / S&P 3.76% / 6.81% |
WinNUWE / S&P 138.59% / 7.78% |
| 2023-Q31/3 |
LoseNUWE / S&P -46.84% / -3.27% |
WinNUWE / S&P 10.27% / 7.52% |
LoseNUWE / S&P -60.15% / -5.03% |
| 2023-Q20/3 |
LoseNUWE / S&P -44.65% / 8.74% |
LoseNUWE / S&P 8.79% / 9.50% |
LoseNUWE / S&P -63.49% / -8.57% |
| 2023-Q10/3 |
LoseNUWE / S&P -54.66% / 7.50% |
LoseNUWE / S&P 6.48% / 10.77% |
LoseNUWE / S&P -85.65% / -15.69% |
| 2022-Q40/3 |
LoseNUWE / S&P -80.15% / 7.56% |
LoseNUWE / S&P 7.85% / 11.88% |
LoseNUWE / S&P -70.76% / -17.99% |
| 2022-Q31/3 |
LoseNUWE / S&P -8.47% / -4.88% |
LoseNUWE / S&P -5.73% / 13.47% |
WinNUWE / S&P 16063.86% / -1.41% |
| 2022-Q21/3 |
LoseNUWE / S&P -41.58% / -16.10% |
LoseNUWE / S&P -8.84% / 13.71% |
WinNUWE / S&P 9494.50% / 11.04% |
| 2022-Q11/3 |
LoseNUWE / S&P -11.40% / -4.60% |
LoseNUWE / S&P 2.59% / 15.97% |
WinNUWE / S&P 5167.10% / 42.23% |
| 2021-Q41/3 |
LoseNUWE / S&P -48.18% / 11.03% |
LoseNUWE / S&P 6.45% / 15.00% |
WinNUWE / S&P 1672.52% / 96.40% |
| 2021-Q31/3 |
LoseNUWE / S&P -47.62% / 0.58% |
WinNUWE / S&P 23.05% / 10.77% |
LoseNUWE / S&P NUWE unavailable / 69.42% |
| 2021-Q21/3 |
LoseNUWE / S&P -28.93% / 8.55% |
WinNUWE / S&P 37.01% / 6.58% |
LoseNUWE / S&P NUWE unavailable / 51.81% |
| 2021-Q11/3 |
LoseNUWE / S&P -15.21% / 6.17% |
WinNUWE / S&P 30.43% / -1.06% |
LoseNUWE / S&P NUWE unavailable / 7.39% |
| 2020-Q41/3 |
LoseNUWE / S&P -19.89% / 12.15% |
WinNUWE / S&P 35.02% / -3.72% |
LoseNUWE / S&P NUWE unavailable / -33.42% |
| 2020-Q31/3 |
LoseNUWE / S&P -39.58% / 8.93% |
WinNUWE / S&P 19.87% / -2.04% |
LoseNUWE / S&P NUWE unavailable / -27.10% |
| 2020-Q21/3 |
LoseNUWE / S&P 9.09% / 20.54% |
WinNUWE / S&P 6.22% / -0.46% |
LoseNUWE / S&P NUWE unavailable / -27.11% |
| 2020-Q11/3 |
LoseNUWE / S&P -48.84% / -19.60% |
WinNUWE / S&P 14.49% / 3.47% |
LoseNUWE / S&P NUWE unavailable / -14.75% |
| 2019-Q41/3 |
LoseNUWE / S&P -42.67% / 9.07% |
WinNUWE / S&P 10.26% / 5.36% |
LoseNUWE / S&P NUWE unavailable / 2.99% |
| 2019-Q31/3 |
LoseNUWE / S&P -48.45% / 1.70% |
WinNUWE / S&P 30.32% / 5.02% |
LoseNUWE / S&P NUWE unavailable / 0.21% |
| 2019-Q21/3 |
LoseNUWE / S&P -29.20% / 4.30% |
WinNUWE / S&P 46.64% / 6.64% |
LoseNUWE / S&P NUWE unavailable / 8.65% |
| 2019-Q11/3 |
LoseNUWE / S&P -40.09% / 13.65% |
WinNUWE / S&P 40.31% / 8.12% |
LoseNUWE / S&P NUWE unavailable / 14.29% |
| 2018-Q41/3 |
LoseNUWE / S&P -58.47% / -13.52% |
WinNUWE / S&P 40.67% / 9.05% |
LoseNUWE / S&P NUWE unavailable / 18.23% |
| 2018-Q31/3 |
LoseNUWE / S&P -35.87% / 7.71% |
WinNUWE / S&P 24.86% / 10.21% |
LoseNUWE / S&P NUWE unavailable / 19.06% |
| 2018-Q21/3 |
LoseNUWE / S&P -34.05% / 3.43% |
WinNUWE / S&P 28.49% / 9.03% |
LoseNUWE / S&P NUWE unavailable / 14.46% |
| 2018-Q11/3 |
LoseNUWE / S&P -19.36% / -0.76% |
WinNUWE / S&P 68.45% / 7.68% |
LoseNUWE / S&P NUWE unavailable / 12.46% |
| 2017-Q40/3 |
LoseNUWE / S&P -70.68% / 6.64% |
LoseNUWE / S&P NUWE unavailable / 7.03% |
LoseNUWE / S&P NUWE unavailable / 13.82% |
| 2017-Q30/3 |
LoseNUWE / S&P -42.72% / 4.48% |
LoseNUWE / S&P NUWE unavailable / 5.68% |
LoseNUWE / S&P NUWE unavailable / 17.57% |
| 2017-Q20/3 |
LoseNUWE / S&P -43.41% / 3.09% |
LoseNUWE / S&P NUWE unavailable / 4.83% |
LoseNUWE / S&P NUWE unavailable / 17.74% |
| 2017-Q10/3 |
LoseNUWE / S&P -82.67% / 6.07% |
LoseNUWE / S&P NUWE unavailable / 3.67% |
LoseNUWE / S&P NUWE unavailable / 13.32% |
| 2016-Q40/3 |
LoseNUWE / S&P -37.50% / 3.82% |
LoseNUWE / S&P NUWE unavailable / 2.09% |
LoseNUWE / S&P NUWE unavailable / 7.05% |
| 2016-Q31/3 |
WinNUWE / S&P 21.74% / 3.85% |
LoseNUWE / S&P NUWE unavailable / 0.20% |
LoseNUWE / S&P NUWE unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | NUWE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.45% | 20.78% |
| Annualized return | -99.45% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | NUWE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 83.14% |
| Annualized return | -96.56% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | NUWE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -93.74% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |